| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |